Moffitt Cancer Center Appoints Dr. Martin J. Murphy Jr. to Board of Advisors

June 17, 2008

Tampa, FLMoffitt Cancer Center has announced that prominent cancer researcher and consultant Martin J. Murphy Jr., Ph.D., has joined its national Board of Advisors. Chaired by veteran ABC newsman Sam Donaldson, the advisors serve as Moffitt ambassadors and offer their expertise, advice and counsel on issues relating to the cancer center.

            Murphy is founding chairman and CEO of AlphaMed Consulting Inc., a Durham, N.C., corporation that provides strategic support for academic cancer centers and cancer drug development programs for global pharmaceutical and biotechnology companies. He also is executive editor of two peer-reviewed journals, The Oncologist and Stem Cells.

            He founded the Hipple Cancer Research Center in 1977 and served as its CEO until 1997. In 1998, he founded AlphaMed Consulting to advance new discoveries and enhance improved health care delivery worldwide. He was principal investigator for $2l million in peer-reviewed grants, as well as author of more than 150 peer-reviewed papers, editor of a score of books and chapters, and a sought-after speaker.

            A member of the board of trustees of the American Cancer Society Foundation, Murphy is a charter member of C-Change, which is co-chaired by former President George Bush and first lady Barbara Bush, and convener of the CEO Roundtable on Cancer, founded by Robert A. Ingram, also a Moffitt Advisor, at the request of former President Bush.  CEO Roundtable members include the chief executives of more than 40 of America’s greatest companies.

            Martin helped spearhead the “CEO Cancer Gold Standard,” the first accreditation process that invites companies to evaluate every aspect of its benefits and culture and take extensive, concrete actions to fight cancer in the workplace.

About H. Lee Moffitt Cancer Center & Research Institute

Located in Tampa, Florida, Moffitt Cancer Center is the only Florida-based cancer center with the NCI designation as a Comprehensive Cancer Center for its excellence in research and contributions to clinical trials, prevention and cancer control. Moffitt currently has 15 affiliates in Florida, one in Georgia and two in Puerto Rico. Additionally, Moffitt is a member of the National Comprehensive Cancer Network, a prestigious alliance of the country’s leading cancer centers, and is listed in U.S. News & World Report as one of “America’s Best Hospitals” for cancer, as well as for ear, nose and throat. Moffitt’s sole mission is to contribute to the prevention and cure of cancer.